ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,129Medicare Part D Prescriptions Filled, Including Refills

Rank: 255 out of 1904

$510K Total Retail Price of All Prescriptions

Rank: 481 out of 1904

394 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

19% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
NAMENDA 545 545 53 1 28
AMLODIPINE BESYLATE 424 419* 70 2 6
FUROSEMIDE 346 329 63 3 7
LEVOTHYROXINE SODIUM 314 309* 59 4 1
HYDROCODONE-ACETAMINOPHEN 286 275 71 S3 5 2
DONEPEZIL HCL 270 270 50 6 32
MIRTAZAPINE 261 261 45 7 57
PRAVASTATIN SODIUM 252 247* 46 8 10
LISINOPRIL 250 245* 57 9 3
LORAZEPAM 213 208* 66 B 10 36
GABAPENTIN 209 204* 37 11 13
FAMOTIDINE* 201 196* 39 12 67
METOPROLOL TARTRATE 189 184* 40 13 12
CITALOPRAM HBR 183 183 26 14 22
TRAMADOL HCL 179 179 49 15 18
WARFARIN SODIUM 174 174 19 16 14
SERTRALINE HCL 167 167 25 17 25
DIVALPROEX SODIUM 163 158* 27 18 86
POTASSIUM CHLORIDE 160 155* 40 19 17
ALPRAZOLAM 140 135* 29 B 20 15
CARVEDILOL 134 129* 34 21 24
TAMSULOSIN HCL 123 123 21 22 26
ESCITALOPRAM OXALATE 119 119 13 23 39
OMEPRAZOLE 119 114* 41 23 5
CLOPIDOGREL 113 113 21 25 20
ZOLPIDEM TARTRATE 110 105* 19 26 30
NYSTATIN 106 106 31 27 96
METFORMIN HCL 105 105 20 28 9
CARBIDOPA-LEVODOPA 103 103 16 29 113
LEVETIRACETAM 100 95* 13 30 101
GLIPIZIDE 100 100 12 30 73
HYDROCHLOROTHIAZIDE 98 93* 24 32 11
PANTOPRAZOLE SODIUM 94 89* 33 33 27
SIMVASTATIN 93 74 24 34 4
FENTANYL 89 84* 12 S2 35 74
CLONAZEPAM 86 81* 16 B 36 44
ALLOPURINOL 84 84 12 37 31
ATORVASTATIN CALCIUM 79 74* 19 38 8
SPIRIVA 77 77 15 39 62
LIDODERM 77 77 14 39 171
LANTUS 73 68* 19 41 55
LEVOFLOXACIN 65 60* 34 42 71
OXYCODONE-ACETAMINOPHEN 65 60* 16 S2 42 97
VANCOMYCIN HCL* 64 <11 <11 44 329
QUETIAPINE FUMARATE 63 63 11 A 45 77
CIPROFLOXACIN HCL 62 62 33 46 65
LOSARTAN POTASSIUM 61 56* 13 47 21
ALBUTEROL SULFATE 60 55* 26 48 127
LACTULOSE 60 <11 <11 48 184
COLCRYS 57 <11 <11 50 239
MORPHINE SULFATE ER 56 <11 <11 S2 51 109
METOPROLOL SUCCINATE 56 56 13 51 16
HYDRALAZINE HCL 55 55 19 53 105
KLOR-CON M10 55 55 14 53 145
ATENOLOL 55 55 12 53 19
RISPERIDONE 54 <11 <11 A 56 82
CYMBALTA 54 <11 <11 56 34
NITROFURANTOIN MONO-MACRO 53 53 20 58 153
OXYBUTYNIN CHLORIDE ER 53 <11 <11 58 129
EXELON 51 51 11 60 123
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.